Equine healthcare market to hit $2.02 billion by 2030

By AI, Created 11:18 AM UTC, May 20, 2026, /AGP/ – The equine healthcare market is projected to grow from $1.58 billion in 2026 to $2.02 billion by 2030, driven by rising horse populations, more equestrian participation and faster adoption of diagnostics and precision medicine. North America held the largest share in 2025, while zoonotic disease pressure is adding demand for preventive care and treatment.

Why it matters: - The equine healthcare market is expanding as horse owners, riders and veterinarians spend more on prevention, treatment and performance care. - Faster growth in diagnostics, medicines and veterinary services could reshape how horses are monitored and treated across racing, leisure and competitive riding. - Zoonotic disease risks are adding urgency to preventive care, diagnostics and treatment options that protect animal and human health.

What happened: - The Business Research Company said the equine healthcare market is projected to rise from $1.48 billion in 2025 to $1.58 billion in 2026. - The report forecasts the market will reach $2.02 billion by 2030, implying a 6.4% compound annual growth rate. - North America held the largest share of the market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Equine healthcare includes veterinary care, nutrition support, grooming, hoof maintenance, vaccinations, parasite control, dental treatment and protection from harsh weather. - Historical growth has been supported by a larger horse population, more horse racing and competitive riding, and greater awareness of equine nutrition and health. - Growth has also come from advances in veterinary medicines and vaccines, plus the expansion of specialized equine healthcare facilities. - Future demand is expected to come from precision medicine, genomics, performance optimization, disease prevention, diagnostic technologies and online distribution channels for equine medicines. - The report expects stronger investment in veterinary services for both leisure and competitive horses. - Key forecast-period trends include wider use of preventive healthcare and routine veterinary services. - The report also points to growing demand for vaccines for core and risk-based equine diseases. - Increased use of anti-inflammatory drugs, antibiotics, pain management drugs, nutritional supplements and performance enhancers is also expected. - Veterinary hospitals, retail pharmacies and e-commerce platforms are projected to keep expanding. - A December 2025 European Centre for Disease Prevention and Control report said campylobacteriosis was the most frequently reported zoonotic disease in humans during 2024, with 168,396 cases, or 55.3 cases per 100,000 people. - The report links rising zoonotic disease risk to closer human-animal contact, urban expansion, deforestation and intensive farming.

Between the lines: - The market story is shifting from basic horse care to a broader health-management model centered on prevention, performance and data-driven treatment. - Online sales and e-commerce growth suggest equine medicine distribution is moving closer to the retail patterns seen in broader animal health markets. - The zoonotic disease angle gives the market a public-health dimension that could keep preventive spending elevated.

What’s next: - The report expects continued growth through 2030 as precision medicine, genomics and diagnostic tools become more common in equine care. - Market expansion will likely depend on how quickly veterinary providers, pharmacies and online channels scale to meet demand. - Regional opportunities remain outside North America as equine care gains attention worldwide.

The bottom line: - Equine healthcare is becoming a more advanced, prevention-focused market, with a clear growth path to $2.02 billion by 2030.